DEFEROXAMINE
UNII J06Y7MXW4D

Substance Identification & Data

This profile provides standardized clinical and technical data for Deferoxamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J06Y7MXW4D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 70-51-9 and the RxNorm Concept ID (RxCUI) 3131. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

J06Y7MXW4D

CAS Registry Number

70-51-9

RxNorm Concept ID

3131

Detailed Substance Profile

Preferred Name

DEFEROXAMINE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

J06Y7MXW4D

The specific atomic composition represented as a molecular structure string.

InChIKey

C25H48N6O8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UBQYURCVBFRUQT-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C416

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

2973

Unique identification number in the NCBI database of chemical substances.

INN ID

1682

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(N(O)CCCCCN)(=O)CCC(=O)NCCCCCN(C(=O)CCC(=O)NCCCCCN(C(=O)C)O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Deferoxamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.